TickerFacts.

BillionToOne, Inc. (BLLN): Gross Profit

Annual figures by period end, from SEC filings.

$208.46M
Year ended 2025-12-31
$283.22M
Trailing 12 months to 2026-06-30
2023-12-31: $17.31M2024-12-31: $80.92M2025-12-31: $208.46M$208.46M
2023-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$208.46M+157.6%2026-03-11, From 2025-01-01
2024-12-31$80.92M+367.5%2026-03-11, From 2024-01-01
2023-12-31$17.31Mn/a2026-03-11, From 2023-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
BillionToOne, Inc. (BLLN)2025-12-31$208.46M+157.6%
Fulgent Genetics, Inc. (FLGT)2025-12-31$130.88M+22.1%
Castle Biosciences Inc (CSTL)2025-12-31$273.20M+0.5%
Veracyte, Inc. (VCYT)2025-12-31$362.53M+21.6%
Guardant Health, Inc. (GH)2025-12-31$633.01M+40.9%
Personalis, Inc. (PSNL)2025-12-31$15.78M-41.2%
Exagen Inc. (XGN)2025-12-31$38.80M+17.2%
American Shared Hospital Services (AMS)2025-12-31$5.06M-44.9%
Quest Diagnostics Inc (DGX)2025-12-31$3.67B+13.0%

Compare BLLN, FLGT, CSTL, VCYT side by side · Screen every company in Services-Medical Laboratories ↗